23 results
Table of Antibiotics for Highly Resistant Gram Negative Infections 

Ceftazidime, Cefepime, Piperacillin/ Tazobactam, Carbapenems, Aztreonam, Aminoglycosides
Antibiotics for Highly Resistant ... #GramNegative # ... Infections #Table #Pharmacology ... #Coverage #Management ... #resistance
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... with Multidrug-Resistant ... #Tuberculosis #MDRTB ... #management #Treatment ... antimicrobials #pharmacology
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Osteomyelitis - IDSA ... species, penicillin resistant ... Osteomyelitis #management ... #treatment #pharmacology ... #idsa
IDSA Suggested Empiric Antibiotic Regimens Based on Clinical Severity for Diabetic Foot Infections
Mild (usually treated with
IDSA Suggested Empiric ... Clinical Severity for Diabetic ... • Methicillin-resistant ... #antibiotics #pharmacology ... #idsa #podiatry
Furosemide - Diuretic Resistance Management

#Furosemide #Diuretic #Resistance #Management #Pharmacology #Lasix
Furosemide - Diuretic ... Resistance Management ... #Furosemide #Diuretic ... #Resistance #Management ... #Pharmacology #
Diabetic Peripheral Neuropathy - Pharmacotherapy

Peripheral neuropathy is a common microvascular complication of diabetes. In clinic patients
Diabetic Peripheral ... complication of diabetes ... clinic patients should ... #Pharmacology # ... Management #Medications
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... with multidrug-resistant ... #Tuberculosis #MDRTB ... #management #Treatment ... antimicrobials #pharmacology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... risks, and therapy should ... #pharmacology #pharmacotherapy ... table #comparison #management
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
local pneumococcal resistance ... fluoroquinolone #IDSA ... Treatment #Regimen #Management ... #Guidelines #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... isolate DST result should ... #Tuberculosis #MDRTB ... #management #Treatment ... antimicrobials #regimens #pharmacology